Revolution Medicines, Inc. (RVMD) › Net IncomeRevolution Medicines, Inc. (RVMD) — Net IncomeAnnual figures by fiscal year, from SEC filings.2018: -$41.79M2019: -$47.66M2020: -$108.16M2021: -$187.09M2022: -$248.71M2023: -$436.37M2024: -$600.09M2025: -$1.13B-$1.13B2018Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$1.13B-88.5%2024-$600.09M-37.5%2023-$436.37M-75.5%2022-$248.71M-32.9%2021-$187.09M-73.0%2020-$108.16M-126.9%2019-$47.66M-14.1%2018-$41.79M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share